An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

For patients with IIH, sustainable weight loss offers the most effective and lasting relief from symptoms—and can help ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

Brain swelling, or cerebral edema, is a medical emergency. Learn about the evidence-based treatments doctors use to reduce ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

"That would pose intracranial pressure control as a brand-new, pharmacologically targetable pathway." Mild gastrointestinal side effects (mainly nausea and constipation) occurred in 38% of ...

GLP-1 drug liraglutide could become a new treatment option for the estimated one in seven people worldwide who live with ...

Idiopathic intracranial hypertension is caused by a buildup of cerebrospinal fluid (CSF) in the skull. Intracranial buildup of CSF can cause symptoms like pressure, pain, and vision changes over time.

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, researchers in Italy have found.

Report on how AI is redefining market landscape - The global non-invasive intracranial pressure monitoring devices market size is estimated to grow by USD 126.1 million from 2025-2029, according ...

Billy Joel cancels shows due to a brain disorder. Here’s what to know. Normal pressure hydrocephalus refers to the buildup of fluid around the brain, and it’s treatable, experts say.